KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Inventory: 2009-2024

Historic Inventory for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • Biomarin Pharmaceutical's Inventory rose 17.20% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 17.20%. This contributed to the annual value of $1.2 billion for FY2024, which is 11.33% up from last year.
  • Biomarin Pharmaceutical's Inventory amounted to $1.2 billion in FY2024, which was up 11.33% from $1.1 billion recorded in FY2023.
  • Over the past 5 years, Biomarin Pharmaceutical's Inventory peaked at $1.2 billion during FY2024, and registered a low of $698.5 million during FY2020.
  • Moreover, its 3-year median value for Inventory was $1.1 billion (2023), whereas its average is $1.1 billion.
  • Data for Biomarin Pharmaceutical's Inventory shows a peak YoY grew of 23.83% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Biomarin Pharmaceutical's Inventory stood at $698.5 million in 2020, then increased by 11.18% to $776.7 million in 2021, then rose by 15.12% to $894.1 million in 2022, then grew by 23.83% to $1.1 billion in 2023, then increased by 11.33% to $1.2 billion in 2024.